我国高等药学教育现状研究分析及其发展建议

Research Analysis on Advanced Pharmaceutical Education in China and some Development Proposals

目的分析2004～2013年间我国高等药学教育的研究现状,为教学及管理人员了解国内高等药学教育现状,促进高等药学教育的健康发展提供参考。方法运用文献计量学方法,分析十年来高等药学教育研究论文年度分布及作者署名人次,研究内容分布,登载论文的主要期刊,核心作者分布、第一作者职称及学位、地域分布以及基金项目情况等。结果高等药学教育研究日益受到重视,研究呈稳步上升趋势,研究人群逐年扩大;研究内容广泛,以教学探讨和实践训练为主,缺乏宏观研究;《药学教育》是国内刊载高等药学教育的主要杂志,除此之外,《西北医学教育》杂志刊载相关论文数最多;48名核心作者中,署名第一作者最高论文数达7篇;教学研究人员不够广泛;研究机构稳定,中国药科大学、广东药学院发文量均过百;第一作者主要分布在江苏、广东、上海、浙江等地;基金项目以校级课题为主,总体级别偏低。结论建议拓宽研究领域,运用长期追踪研究或纵贯性研究,深化研究层次,提高研究成果说服力;开展高等药学教育学术载体的研究,规范论文刊载格式。稳定并培养高等药学教育研究核心作者群,并鼓励药学教学核心作者人群多做相关研究。建立高等药学教育研究激励机制,吸纳高层次研究人员,形成结构合理的高等药学教育研究队伍。建议增加高级别基金项目比例,增加基金项目研究经费。

Objective To analyze the research status of advanced pharmaceutical education in China between 2004-2013,so as to provide a reference for educators and administrators to understand the status and to promote the development.Methods Using the bibliometrics to analyze the research of advanced pharmaceutical education in the recent decade,including the annual distribution of literature,the distribution of researchers,the main journals which published the literature,the basic information of authors and the situation of funds.Results The research of advanced pharmaceutical education expanded gradually and received increasing attention.However,it was insufficient in depth,which focused on teaching discussion and practical training,and lacked in macro studies.The journal that contained the most related papers was Pharmaceutical Education,followed by Northwest Medical Education.Of the 48 coreauthors,the maximum number of papers with first authorship was 7.The distribution of teaching researchers was not wide;but research institutions were distributed regularly,and first authors were mainly in Jiangsu,Guangdong,Zhejiang and Shanghai.Research projects were mainly supported by colonel-level funds.ConclusionIt was proposed that research scope be broadened using longitudinal study,study be conducted on academic journals to standardize format,a stable core-author team be cultivated to encourage more teaching researchers,and an incentive system be established to absorb advanced researchers.In addition,more higher-rank funds should be set up to increase investment in advanced pharmaceutical education.